GO:0052642 lysophosphatidic acid phosphatase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0052642 (lysophosphatidic acid phosphatase activity) catalyzes the hydrolysis of lysophosphatidic acid (LPA) to monoacylglycerol and inorganic phosphate, thereby terminating LPA signaling.
• The reaction is magnesium-independent and distinct from lipid phosphate phosphatases; the best-characterized human enzyme is ACP6 (lysophosphatidic acid phosphatase type 6).
• ACP6 is a mitochondrial/peroxisomal enzyme that regulates mitochondrial lipid biosynthesis and is translocated to the plasma membrane in response to GnRH in ovarian cancer cells.
• Prostatic acid phosphatase (ACPP) in seminal plasma also degrades LPA, linking this activity to reproductive biology.
• The activity is conserved across plants (peanut, Arabidopsis) and animals (fish, human), underscoring its fundamental role in lipid metabolism.
• Dysregulation of LPA phosphatase activity is implicated in cancer progression, mitochondrial dysfunction, and metabolic disorders.
Description
Lysophosphatidic acid phosphatase activity (GO:0052642) is a molecular function that removes the phosphate group from lysophosphatidic acid (LPA), yielding monoacylglycerol and free phosphate. This reaction is critical for terminating LPA signaling, as LPA is a potent bioactive lipid that promotes cell proliferation, migration, and survival. The enzyme responsible for this activity in humans, ACP6, was first cloned and characterized as a mitochondrial enzyme involved in lipid biosynthesis. Subsequent structural and biochemical studies confirmed its catalytic mechanism and substrate specificity. In seminal plasma, prostatic acid phosphatase (ACPP) also exhibits LPA phosphatase activity, suggesting a role in reproductive physiology. The activity is evolutionarily conserved, with homologs identified in plants such as peanut and Arabidopsis, and in fish like golden pompano. Researchers study this activity to understand lipid signaling, mitochondrial function, and diseases including cancer and metabolic disorders.
lysophosphatidic acid phosphatase activity At A Glance
| GO ID | GO:0052642 |
|---|---|
| GO term | lysophosphatidic acid phosphatase activity |
| Ontology | molecular_function |
| Synonym | LPA phosphatase activity; 1-acyl-sn-glycerol 3-phosphatase activity; 2-lysophosphatidate phosphatase activity; lysophosphatidate phosphatase activity |
| Major function | Hydrolysis of lysophosphatidic acid to monoacylglycerol and phosphate |
| Reaction | lysophosphatidic acid + H2O = phosphate + monoacylglycerol |
| Cofactors | None required; magnesium-independent |
| Subcellular location | Mitochondria, peroxisomes, plasma membrane (upon stimulation) |
| Representative enzyme | ACP6 (human), ACPP (prostatic acid phosphatase) |
What Is GO:0052642?
According to the Gene Ontology, GO:0052642 describes the catalysis of the reaction: lysophosphatidic acid + H2O = phosphate + monoacylglycerol. In other words, it is the enzymatic removal of a phosphate group from LPA, a lysophospholipid, to produce monoacylglycerol and inorganic phosphate. This activity is also known as LPA phosphatase activity, 1-acyl-sn-glycerol 3-phosphatase activity, or 2-lysophosphatidate phosphatase activity.
Why Is lysophosphatidic acid phosphatase activity Important in Cell Biology?
Lysophosphatidic acid phosphatase activity is essential for controlling the levels of LPA, a lipid mediator with diverse biological functions. By degrading LPA, this activity acts as a negative regulator of LPA signaling, which is involved in cell proliferation, migration, and survival. Dysregulation of this activity can lead to pathological conditions such as cancer, where increased LPA signaling promotes tumor progression. Additionally, the enzyme ACP6 is linked to mitochondrial lipid biosynthesis, and its dysfunction may contribute to metabolic disorders. Understanding this activity provides insights into lipid metabolism and potential therapeutic targets.
• Terminates LPA signaling, preventing excessive cell proliferation and migration.
• Regulates mitochondrial lipid biosynthesis and energy metabolism.
• Involved in reproductive biology through seminal plasma ACPP.
• Implicated in ovarian cancer progression via GnRH-induced translocation.
• Conserved across plants and animals, indicating fundamental role in lipid metabolism.
• Potential biomarker for prostate cancer and metabolic diseases.
• Target for modulating LPA levels in inflammatory and fibrotic diseases.
• Provides a mechanism for cross-talk between lipid signaling and mitochondrial function.
• Enables studies of enzyme kinetics and substrate specificity for drug development.
• Contributes to the broader family of lipid phosphate phosphatases with distinct roles.
Molecular Mechanism of lysophosphatidic acid phosphatase activity
Substrate recognition and binding
In simple terms: The enzyme grabs LPA and holds it in place.
The enzyme specifically binds lysophosphatidic acid (LPA), a glycerophospholipid with a single fatty acyl chain. Structural studies of human ACP6 reveal a conserved catalytic pocket that accommodates the LPA headgroup, with key residues forming hydrogen bonds with the phosphate and glycerol backbone. The enzyme discriminates LPA from other phospholipids, ensuring specificity for the lysophosphatidic acid substrate.
Catalytic hydrolysis
In simple terms: Water attacks the phosphate, breaking it off.
The catalytic mechanism involves a nucleophilic attack by a water molecule on the phosphorus atom of LPA, leading to the cleavage of the phosphoester bond and release of inorganic phosphate and monoacylglycerol. This reaction does not require metal ions, distinguishing it from some other phosphatases. Mutagenesis studies identified essential residues in the active site of ACP6 that are critical for catalysis.
Product release and enzyme turnover
In simple terms: The products leave, and the enzyme is ready for another round.
After hydrolysis, monoacylglycerol and phosphate are released from the active site, allowing the enzyme to catalyze subsequent reactions. The reaction is reversible in vitro under certain conditions, but in vivo the hydrolysis is favored. The enzyme's activity can be modulated by changes in substrate availability and cellular localization.
Regulation by subcellular localization
In simple terms: The enzyme moves to different parts of the cell to do its job.
In ovarian cancer cells, lysophosphatidic acid phosphatase is translocated to the plasma membrane in response to gonadotropin-releasing hormone (GnRH), where it can degrade extracellular LPA. This translocation is a regulatory mechanism that links hormonal signaling to LPA degradation. In mitochondria, ACP6 regulates lipid biosynthesis, and its localization is essential for its function.
Tissue-specific expression and isoforms
In simple terms: Different tissues have different versions of the enzyme.
Human ACP6 is expressed in various tissues, with highest levels in the liver, kidney, and heart. Prostatic acid phosphatase (ACPP) is abundant in seminal plasma and also exhibits LPA phosphatase activity, suggesting tissue-specific roles. In plants, LPA phosphatase from peanut cotyledons and Arabidopsis has been characterized, showing similar catalytic properties but distinct physiological roles.
Key Genes Involved in GO:0052642 lysophosphatidic acid phosphatase activity
The following genes and proteins are directly associated with lysophosphatidic acid phosphatase activity, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ACP6 | Human lysophosphatidic acid phosphatase type 6; hydrolyzes LPA in mitochondria and peroxisomes | Mitochondrial lipid biosynthesis, cancer metabolism |
| ACPP | Prostatic acid phosphatase; degrades LPA in seminal plasma | Reproductive biology, prostate cancer |
| PLPP1 | Lipid phosphate phosphatase 1; can dephosphorylate LPA but with broader specificity | LPA signaling regulation |
| PLPP2 | Lipid phosphate phosphatase 2; hydrolyzes LPA and other lipid phosphates | Cell migration and cancer |
| PLPP3 | Lipid phosphate phosphatase 3; involved in LPA degradation | Vascular development |
| AT1G15080 | Arabidopsis LPA phosphatase; involved in lipid metabolism | Plant lipid signaling |
| AhLPP | Peanut LPA phosphatase; isolated from cotyledons | Seed development |
| ACP6 (fish) | Golden pompano ACP6; involved in immune response | Fish immunology |
| LPP1 | Yeast lipid phosphate phosphatase; homolog of mammalian PLPPs | Fungal lipid metabolism |
| LPP2 | Yeast lipid phosphate phosphatase; regulates LPA levels | Fungal stress response |
| Sgpp1 | Sphingosine-1-phosphate phosphatase; related activity but distinct substrate | Sphingolipid metabolism |
| Sgpp2 | Sphingosine-1-phosphate phosphatase; related family member | Sphingolipid signaling |
| PPAP2A | Phosphatidic acid phosphatase 2A; also known as PLPP1 | LPA degradation |
| PPAP2B | Phosphatidic acid phosphatase 2B; also known as PLPP3 | LPA signaling |
| PPAP2C | Phosphatidic acid phosphatase 2C; also known as PLPP2 | LPA metabolism |
| LPAAT | Lysophosphatidic acid acyltransferase; opposing enzyme that adds acyl chain to LPA | Lipid biosynthesis |
| MitoPLD | Mitochondrial phospholipase D; produces LPA in mitochondria | Mitochondrial dynamics |
How Is lysophosphatidic acid phosphatase activity Regulated?
Lysophosphatidic acid phosphatase activity is regulated at multiple levels. In ovarian cancer cells, gonadotropin-releasing hormone (GnRH) induces translocation of the enzyme to the plasma membrane, enhancing LPA degradation. The expression of ACP6 is regulated by developmental and metabolic cues, as seen in fish where ACP6 is upregulated in response to immune challenges. In plants, LPA phosphatase activity is modulated during seed development and germination. Additionally, the activity can be influenced by substrate availability and the presence of other lipid phosphate phosphatases.
lysophosphatidic acid phosphatase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ACP6 | Ovarian cancer, mitochondrial dysfunction | ACP6 knockout ovarian cancer cell line (e.g., SKOV3) |
| ACPP | Prostate cancer, male infertility | ACPP knockout mouse model or prostate cancer cell lines |
| PLPP1 | Cancer, cardiovascular disease | PLPP1 knockout mice or endothelial cells |
| PLPP3 | Vascular disorders, cancer | PLPP3 knockout zebrafish or human cell lines |
| ACP6 (fish) | Immune response in fish | Golden pompano ACP6 knockdown |
Cancer
LPA is a well-known promoter of cancer cell proliferation, migration, and survival. Lysophosphatidic acid phosphatase activity counteracts these effects by degrading LPA. In ovarian cancer cells, GnRH stimulates translocation of LPA phosphatase to the plasma membrane, potentially reducing LPA signaling. In prostate cancer, prostatic acid phosphatase (ACPP) in seminal plasma degrades LPA, and its levels are altered in disease. Thus, dysregulation of LPA phosphatase activity may contribute to cancer progression.
Metabolic disorders
ACP6 is involved in mitochondrial lipid biosynthesis, and its dysfunction may lead to metabolic imbalances. The enzyme's role in regulating mitochondrial lipid composition suggests that it could be implicated in disorders such as obesity and diabetes, although direct evidence is still emerging.
Reproductive biology
Prostatic acid phosphatase (ACPP) in seminal plasma degrades LPA, which is present in high concentrations in semen. This activity may regulate LPA's effects on sperm motility and fertilization. Additionally, GnRH-induced translocation of LPA phosphatase in ovarian cancer cells links reproductive hormones to LPA metabolism.
From lysophosphatidic acid phosphatase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of ACP6 loss on mitochondrial lipid composition? | ACP6 knockout HeLa or HEK293 cells |
| How does GnRH regulate LPA phosphatase translocation? | Ovarian cancer cells with tagged ACP6 and live imaging |
| Does ACP6 point mutation affect catalytic activity? | Recombinant ACP6 mutants expressed in E. coli |
| Can ACP6 overexpression reduce LPA-induced migration? | Cancer cell lines with doxycycline-inducible ACP6 |
| What is the role of ACPP in seminal plasma LPA degradation? | ACPP knockout mouse model |
| Is ACP6 involved in immune response in fish? | Golden pompano with ACP6 knockdown |
How to Study the lysophosphatidic acid phosphatase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioenzymatic assay | LPA phosphatase activity | Kinetic analysis of recombinant ACP6 |
| X-ray crystallography | Three-dimensional structure | Active site mapping of ACP6 |
| Fluorescence microscopy | Subcellular localization | GnRH-induced translocation in ovarian cancer cells |
| Subcellular fractionation | Organelle distribution | Mitochondrial localization of ACP6 |
| qRT-PCR | mRNA expression levels | Tissue-specific expression of ACP6 |
| Western blotting | Protein expression and modification | Detection of ACP6 in cell lysates |
| RNA-seq | Transcriptome-wide expression | Identifying ACP6-regulated genes |
| Site-directed mutagenesis | Functional importance of residues | Catalytic residue identification in ACP6 |
Enzymatic activity assays
LPA phosphatase activity is typically measured using radiolabeled or fluorescent LPA substrates, followed by separation of products via thin-layer chromatography or high-performance liquid chromatography. These assays allow determination of kinetic parameters such as Km and Vmax.
Structural biology
X-ray crystallography and cryo-electron microscopy have been used to solve the structure of human ACP6, revealing the active site and substrate binding pocket. These studies provide a basis for understanding catalytic mechanism and for designing inhibitors.
Subcellular localization studies
Fluorescence microscopy with tagged ACP6 (e.g., GFP fusion) has been used to track its localization in live cells, including translocation to the plasma membrane upon GnRH stimulation. Subcellular fractionation followed by Western blotting can confirm mitochondrial and peroxisomal localization.
Gene expression analysis
Quantitative RT-PCR and RNA-seq are used to measure ACP6 mRNA levels in different tissues and conditions, such as in fish immune challenge or plant development. These methods help link expression to physiological roles.
How CRISPR Can Be Used to Study GO:0052642 lysophosphatidic acid phosphatase activity
Knockout
CRISPR-Cas9 knockout of ACP6 in human cell lines (e.g., HeLa, HEK293) can abolish LPA phosphatase activity, leading to accumulation of LPA and altered mitochondrial lipid composition. Such models are useful to study the consequences of loss of function in cancer and metabolic disorders.
Point Mutation
Introducing point mutations in the catalytic residues of ACP6 (e.g., Asp, His, or Arg) via CRISPR base editing or homology-directed repair can dissect the enzymatic mechanism and separate catalytic activity from other functions. These mutants can be expressed in ACP6-null cells to assess specific activity.
Knock-in
Knock-in of a tagged ACP6 (e.g., GFP or FLAG) at the endogenous locus allows real-time tracking of protein localization and interaction without overexpression artifacts. This approach is valuable for studying GnRH-induced translocation in ovarian cancer cells.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of ACP6 can increase LPA degradation, potentially reducing LPA-induced phenotypes such as cell migration. Overexpression models are useful for gain-of-function studies and for testing therapeutic hypotheses.
How EDITGENE Supports lysophosphatidic acid phosphatase activity Research
Researchers studying lysophosphatidic acid phosphatase activity-related genes often need to determine whether a candidate gene is causally involved in lipid metabolism, cancer progression, or mitochondrial function. EDITGENE provides comprehensive CRISPR-based services to create precisely engineered cell models, enabling rigorous functional studies.
Contact EDITGENE today to design your custom CRISPR model for lysophosphatidic acid phosphatase activity research.
Frequently Asked Questions About lysophosphatidic acid phosphatase activity
What is lysophosphatidic acid phosphatase activity?
It is the enzymatic activity that removes a phosphate group from lysophosphatidic acid (LPA) to produce monoacylglycerol and phosphate, as defined by GO:0052642.
What genes are involved in lysophosphatidic acid phosphatase activity?
The main human genes are ACP6 (lysophosphatidic acid phosphatase type 6) and ACPP (prostatic acid phosphatase); other lipid phosphate phosphatases like PLPP1-3 also have related activity.
What is the function of ACP6?
ACP6 is a mitochondrial and peroxisomal enzyme that hydrolyzes LPA and regulates mitochondrial lipid biosynthesis.
How is lysophosphatidic acid phosphatase activity regulated?
It is regulated by subcellular translocation (e.g., GnRH-induced plasma membrane translocation), expression levels, and substrate availability.
What diseases are associated with lysophosphatidic acid phosphatase?
Dysregulation is linked to cancer (ovarian, prostate), metabolic disorders, and reproductive biology.
What is the reaction catalyzed by LPA phosphatase?
Lysophosphatidic acid + H2O = phosphate + monoacylglycerol.
Is lysophosphatidic acid phosphatase a metal-dependent enzyme?
No, it is magnesium-independent, unlike some other phosphatases.
What are the synonyms for lysophosphatidic acid phosphatase activity?
LPA phosphatase activity, 1-acyl-sn-glycerol 3-phosphatase activity, 2-lysophosphatidate phosphatase activity, lysophosphatidate phosphatase activity.
How can I study lysophosphatidic acid phosphatase activity in the lab?
Common methods include enzymatic assays with radiolabeled LPA, Western blotting, qRT-PCR, and fluorescence microscopy for localization.
What model organisms are used to study LPA phosphatase?
Human cell lines, mice, Arabidopsis, peanut, and golden pompano are used, reflecting its conservation.
Conclusion
Lysophosphatidic acid phosphatase activity (GO:0052642) is a critical enzymatic function that regulates LPA levels and downstream signaling. Its roles in mitochondrial lipid metabolism, cancer, and reproduction make it a compelling target for basic and translational research. The availability of CRISPR models and biochemical assays enables detailed mechanistic and functional studies. EDITGENE provides comprehensive services to support such research, from knockout to knock-in and screening.
References
- 1. Tanaka M et al.. 2004. Prostatic acid phosphatase degrades lysophosphatidic acid in seminal plasma.. FEBS Lett 571(1-3):197-204 PMID: 15280042
- 2. Qiu R et al.. 2024. Identification and functional analysis of lysophosphatidic acid phosphatase type 6 (ACP6) gene in golden pompano (Trachinotusovatus).. Fish Shellfish Immunol 154:109904 PMID: 39276813
- 3. Shekar S et al.. 2002. Isolation of lysophosphatidic acid phosphatase from developing peanut cotyledons.. Plant Physiol 128(3):988-96 PMID: 11891254
- 4. Mandala SM. 2001. Sphingosine-1-phosphate phosphatases.. Prostaglandins Other Lipid Mediat 64(1-4):143-56 PMID: 11324704
- 5. Reddy VS et al.. 2010. Functional characterization of lysophosphatidic acid phosphatase from Arabidopsis thaliana.. Biochim Biophys Acta 1801(4):455-61 PMID: 20045079
- 6. Sun WS et al.. 2004. Translocation of lysophosphatidic acid phosphatase in response to gonadotropin-releasing hormone to the plasma membrane in ovarian cancer cell.. Am J Obstet Gynecol 191(1):143-9 PMID: 15295355
- 7. Li J et al.. 2013. Crystal structures and biochemical studies of human lysophosphatidic acid phosphatase type 6.. Protein Cell 4(7):548-61 PMID: 23807634
- 8. Hiroyama M et al.. 1999. Isolation of a cDNA encoding human lysophosphatidic acid phosphatase that is involved in the regulation of mitochondrial lipid biosynthesis.. J Biol Chem 274(41):29172-80 PMID: 10506173
